Europe’s Vaccination Problem

<p>Europe’s vaccination process was expected to be well-orchestrated and efficient. So far, it’s been neither. Sabrina Tavernise, a national correspondent for The Times, spoke with our colleague Matina Stevis-Gridneff about Europe’s problems and why things could get worse before they get better.</p><p>Guest: <a href="https://www.nytimes.com/by/matina-stevis-gridneff">Matina Stevis-Gridneff</a>, the Brussels correspondent for The New York Times, covering the European Union.</p><p><a href="https://www.nytimes.com/newsletters/signup/NTTD?smid=pc-thedaily">Sign up here</a> to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, <a href="https://www.nytimes.com/newsletters/the-daily?module=inline">subscribe to our newsletter</a>. </p><p>Background reading: </p><ul><li>A cascade of small decisions has led to increasingly <a href="https://www.nytimes.com/2021/03/20/world/europe/europe-vaccine-rollout-astrazeneca.html?smid=pc-thedaily">long delays in the European Union’s inoculation efforts</a>. While Washington went into business with the drug companies, Brussels took a conservative, budget-conscious approach that left the open market largely untouched. And it has paid for it.</li><li>Falling<a href="https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html?smid=pc-thedaily"> behind the pace of vaccine rollouts</a> in countries like Britain, the United States and Israel, Europe is now<a href="https://www.nytimes.com/2021/03/24/world/europe/vaccine-European-Union-export.html?smid=pc-thedaily"> tightening export rules</a> in a bid to speed up its inoculation campaign and stem political criticism.</li></ul><p>For more information on today’s episode, visit <a href="http://nytimes.com/thedaily?smid=pc-thedaily">nytimes.com/thedaily</a>. Transcripts of each episode will be made available by the next workday.</p>